Expensive cancer drugs 'hit budget'

By Melissa Davey
November 15 2012 - 3:00am

CANCER patients are being given expensive drugs that extend their lives by just a few months or provide no benefit, risking a health budget blow-out. Cancer researcher Deme Karikios said the total cost to the federal government of subsidising cancer drugs had risen from $65 million to more than $500 million in the decade to 2010.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options

Get the latest Dubbo news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.